TRY AI DEMO

Large Language Models

How Yseop Leveraged AWS to Develop a Unique Generative AI Application for Document Generation

Blog / By

Explore how Yseop transitioned from AWS SageMaker to AWS Bedrock to overcome scalability challenges and enhance its generative AI capabilities. This strategic move accelerates innovation in regulatory document generation, empowering the pharmaceutical industry with cutting-edge, scalable solutions.

How Yseop Leveraged AWS to Develop a Unique Generative AI Application for Document Generation Read More »

Navigating the Maturity of Generative AI: Yseop’s Approach to Continuous Improvement

Blog / By

Gartner’s analysis indicates a significant shift in generative AI, moving from rapid growth to stabilization and incremental improvements. At Yseop, we embrace this evolution, continuously enhancing our platform to deliver reliable and efficient AI solutions. Learn how we capitalize on the current phase to drive the future of AI-driven content generation.

Navigating the Maturity of Generative AI: Yseop’s Approach to Continuous Improvement Read More »

The Transformative Power of AI in Late-Stage Drug Development

Blog / By

In the ever-evolving pharmaceutical landscape, the integration of artificial intelligence (AI) in clinical trials is a game-changer, enhancing efficiency and effectiveness. By exploring the advantages of AI in late-stage drug development, we reveal how AI optimizes clinical trials, streamlines data collection, and improves patient recruitment and retention. Dive in to discover how AI can transform your drug development process and position your organization at the forefront of innovation.

The Transformative Power of AI in Late-Stage Drug Development Read More »

Scroll to Top